Oregon Public Employees Retirement Fund’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$719K Buy
9,592
+100
+1% +$6.42K 0.01% 1094
2026
Q1
$535K Buy
9,492
+100
+1% +$6.51K 0.01% 1147
2025
Q4
$753K Sell
9,392
-300
-3% -$20.2K 0.01% 990
2025
Q3
$472K Sell
9,692
-600
-6% -$37.1K 0.01% 1166
2025
Q2
$768K Hold
10,292
0.01% 916
2025
Q1
$654K Buy
10,292
+100
+1% +$6.8K 0.01% 998
2024
Q4
$796K Sell
10,192
-200
-2% -$16.1K 0.01% 921
2024
Q3
$835K Sell
10,392
-200
-2% -$16.2K 0.02% 904
2024
Q2
$876K Sell
10,592
-1,961
-16% -$173K 0.02% 823
2024
Q1
$1.07M Sell
12,553
-1,769
-12% -$139K 0.02% 786
2023
Q4
$1.22M Buy
14,322
+100
+0.7% +$8.64K 0.02% 775
2023
Q3
$1.27M Sell
14,222
-400
-3% -$35.7K 0.02% 812
2023
Q2
$1.24M Sell
14,622
-100
-0.7% -$8.46K 0.01% 872
2023
Q1
$1.22M Sell
14,722
-175
-1% -$14.2K 0.02% 873
2022
Q4
$1.17M Sell
14,897
-89
-0.6% -$7.15K 0.02% 886
2022
Q3
$1.11M Buy
14,986
+89
+0.6% +$6.39K 0.02% 860
2022
Q2
$971K Sell
14,897
-1,500
-9% -$88.8K 0.01% 821
2022
Q1
$1.04M Sell
16,397
-184
-1% -$10K 0.01% 1068
2021
Q4
$879K Sell
16,581
-500
-3% -$30.5K 0.01% 1076
2021
Q3
$1.21M Sell
17,081
-225
-1% -$14.2K 0.01% 890
2021
Q2
$1.15M Buy
17,306
+428
+3% +$30.3K 0.01% 935
2021
Q1
$1.87M Buy
16,878
+110
+0.7% +$13.6K 0.02% 615
2020
Q4
$1.99M Sell
16,768
-338
-2% -$36.4K 0.03% 544
2020
Q3
$1.49M Sell
17,106
-1,788
-9% -$156K 0.02% 589
2020
Q2
$1.69M Sell
18,894
-209
-1% -$21.1K 0.03% 545
2020
Q1
$1.9M Sell
19,103
-140
-0.7% -$15.2K 0.03% 448
2019
Q4
$2.21M Sell
19,243
-1,785
-8% -$216K 0.03% 528
2019
Q3
$2.65M Buy
21,028
+405
+2% +$51.4K 0.03% 510
2019
Q2
$2.48M Buy
20,623
+34
+0.2% +$3.35K 0.03% 526
2019
Q1
$1.8M Hold
20,589
0.03% 635
2018
Q4
$2.06M Buy
20,589
+7,041
+52% +$740K 0.03% 528
2018
Q3
$1.55M Buy
13,548
+13,258
+4,572% +$1.37M 0.02% 766
2018
Q2
$26K Buy
+290
New +$24.5K ﹤0.01% 1090

Other funds holding HAE

Oregon Public Employees Retirement Fund's HAE Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Haemonetics (HAE) stake by 1.1% in Q2 2026, buying an estimated $6.42K and bringing the position to 9,592 shares worth $719K. The position accounts for 0.01% of the portfolio, ranked #1094.

Oregon Public Employees Retirement Fund first reported a position in HAE in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.65M in Q3 2019. 136 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 9,592 shares of Haemonetics worth $719K as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 100 Haemonetics shares in Q2 2026, an estimated $6.42K.
  • Haemonetics made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1094 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Haemonetics in Q2 2018 and has held it in 33 quarters since.
  • Oregon Public Employees Retirement Fund's Haemonetics position peaked at $2.65M in Q3 2019.
  • 136 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.